Citybuzz

Citybuzz

Citybuzz is a vibrant local lifestyle and news media outlet. While primarily reporting on community events and entertainment it also actively covers business innovation and tech trends acting as a window connecting local audiences with modern digital lifestyle trends.

Citybuzz's Articles

Quantum BioPharma Advances Novel MS Therapy Targeting Myelin Repair into Phase 2 Trials

Quantum BioPharma Advances Novel MS Therapy Targeting Myelin Repair into Phase 2 Trials

Quantum BioPharma's Lucid-MS enters phase 2 trials to halt multiple sclerosis progression. Learn how this novel therapy targets myelin repair, offering hope for

Precious Metals Rally as Gold and Silver Prices Surge, Driven by Four Key Forces

Precious Metals Rally as Gold and Silver Prices Surge, Driven by Four Key Forces

Precious metals rally as gold hits $4,362/oz and silver $71.2/oz. Key forces driving this surge include inflation and geopolitics. New Pacific Metals could benefit

Next-Generation DNA Repair Inhibitors Poised to Capture Billions in Growing Oncology Market

Next-Generation DNA Repair Inhibitors Poised to Capture Billions in Growing Oncology Market

Onco-Innovations advances ONC010, a nanoparticle PNKP inhibitor, in the growing DDR inhibitor market. Learn how this precision medicine approach targets cancer

Functional Beverages Become Daily Habit as Wellness Culture Shifts Toward Routine Integration

Functional Beverages Become Daily Habit as Wellness Culture Shifts Toward Routine Integration

Functional beverages move from specialty stores to daily routines as consumers embrace wellness habits. Clean ingredients and convenience drive growth. Discover

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma advances Lucid-MS, a first-in-class drug for multiple sclerosis that protects myelin. Phase 2 trial preparation underway after successful safety

Onco-Innovations Advances Nanoparticle PNKP Inhibitor for DNA Damage Response Cancer Therapies

Onco-Innovations Advances Nanoparticle PNKP Inhibitor for DNA Damage Response Cancer Therapies

Onco-Innovations advances ONC010™, a nanoparticle PNKP inhibitor, targeting the $7B DDR oncology market. Preclinical success in colorectal cancer models and strategic

Cardio Diagnostics Expands Access to Precision Heart Disease Tests Through Atlas Healthcare Physicians

Cardio Diagnostics Expands Access to Precision Heart Disease Tests Through Atlas Healthcare Physicians

Cardio Diagnostics (CDIO) announces Atlas Healthcare coverage for Epi+Gen CHD and PrecisionCHD tests, expanding access to AI-powered coronary heart disease risk

Squeeze-Bottle Tahini Taps Into Pantry Simplicity Trend as Consumers Seek Convenient, Versatile Staples

Squeeze-Bottle Tahini Taps Into Pantry Simplicity Trend as Consumers Seek Convenient, Versatile Staples

Mighty Sesame Co. makes tahini a convenient pantry staple with squeeze-bottle format. Learn how single-ingredient sesame paste simplifies plant-based cooking. The

Gaxos.ai Sells Gaming Assets for $1.76 Million, Focuses on AI Businesses

Gaxos.ai Sells Gaming Assets for $1.76 Million, Focuses on AI Businesses

Gaxos.ai completes sale of gaming assets to Game Foundry AI, focusing on AI businesses. All-stock transaction valued at $1.76M. Stock acquisition maintains investment

Rail Vision Completes ShuntingYard Field Testing with Israel Railways, Advancing Commercialization

Rail Vision Completes ShuntingYard Field Testing with Israel Railways, Advancing Commercialization

Rail Vision (RVSN) announces successful ShuntingYard field testing with Israel Railways, enhancing railway safety with AI-powered obstacle detection. Commercial